Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-02-24

Clinical Trial Update: Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy

View source ↗

Summary

Withdrawal notice for a trial evaluating how frequently portal imaging should be used to enhance quality assurance for breast cancer radiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Breast Cancer | Status: WITHDRAWN